| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
55,154 |
44,429 |
$5.68M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
39,881 |
33,160 |
$5.35M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
7,181 |
4,614 |
$3.87M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,954 |
3,692 |
$2.10M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
24,703 |
6,407 |
$1.64M |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
5,662 |
5,532 |
$1.42M |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,899 |
3,596 |
$1.13M |
| 99201 |
|
4,135 |
2,888 |
$1.07M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,097 |
7,049 |
$1.04M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
7,095 |
6,307 |
$1.01M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,899 |
2,822 |
$916K |
| 97750 |
|
7,882 |
3,985 |
$913K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
4,790 |
4,504 |
$838K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,549 |
12,055 |
$791K |
| J3490 |
Unclassified drugs |
46,866 |
21,454 |
$784K |
| 93975 |
|
1,454 |
1,339 |
$683K |
| 97139 |
|
15,548 |
3,801 |
$649K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,818 |
5,811 |
$649K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
3,993 |
3,737 |
$612K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,685 |
2,742 |
$597K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
4,297 |
2,320 |
$555K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
862 |
816 |
$521K |
| 92557 |
|
2,729 |
2,573 |
$503K |
| 76830 |
Ultrasound, transvaginal |
3,281 |
3,076 |
$503K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,018 |
951 |
$477K |
| 59025 |
Fetal non-stress test |
9,295 |
3,560 |
$404K |
| 99070 |
|
16,297 |
13,071 |
$351K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,490 |
3,838 |
$348K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
626 |
614 |
$340K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
5,603 |
5,475 |
$333K |
| 77066 |
Tomosynthesis, mammo |
1,032 |
995 |
$315K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
417 |
400 |
$288K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
269 |
250 |
$285K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,599 |
1,850 |
$267K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,364 |
3,340 |
$248K |
| 96367 |
|
1,934 |
1,037 |
$238K |
| 90791 |
Psychiatric diagnostic evaluation |
709 |
669 |
$236K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,807 |
1,631 |
$236K |
| J2704 |
Injection, propofol, 10 mg |
6,371 |
5,731 |
$233K |
| 76642 |
|
1,728 |
1,644 |
$224K |
| 71045 |
Radiologic examination, chest; single view |
8,549 |
7,775 |
$218K |
| 80053 |
Comprehensive metabolic panel |
23,795 |
20,038 |
$208K |
| 93971 |
|
844 |
799 |
$203K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,808 |
3,491 |
$195K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
322 |
315 |
$180K |
| 93351 |
|
387 |
370 |
$179K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,913 |
1,536 |
$172K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
26,311 |
21,619 |
$169K |
| 77065 |
Tomosynthesis, mammo |
726 |
628 |
$168K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,021 |
6,399 |
$167K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,992 |
1,848 |
$164K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,889 |
1,629 |
$161K |
| 93976 |
|
369 |
363 |
$159K |
| Z7502 |
|
4,161 |
4,103 |
$157K |
| 71046 |
Radiologic examination, chest; 2 views |
3,838 |
3,680 |
$152K |
| 76770 |
|
779 |
740 |
$132K |
| 96415 |
|
1,146 |
726 |
$131K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,693 |
1,642 |
$122K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
1,408 |
1,314 |
$119K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,187 |
4,567 |
$119K |
| 93325 |
|
392 |
374 |
$117K |
| 73610 |
|
1,904 |
1,771 |
$117K |
| 72141 |
|
205 |
200 |
$116K |
| 73030 |
|
1,922 |
1,841 |
$116K |
| 93990 |
|
714 |
685 |
$113K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
427 |
395 |
$110K |
| 97803 |
|
873 |
749 |
$108K |
| 73630 |
|
1,874 |
1,783 |
$107K |
| 87631 |
|
1,198 |
1,162 |
$106K |
| 73564 |
|
1,544 |
1,465 |
$105K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
8,764 |
7,240 |
$97K |
| 70486 |
|
266 |
244 |
$95K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
9,179 |
7,502 |
$94K |
| 73221 |
|
138 |
134 |
$93K |
| 73130 |
|
1,446 |
1,353 |
$89K |
| 72100 |
|
1,293 |
1,236 |
$86K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
887 |
858 |
$86K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
156 |
149 |
$81K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
7,405 |
6,002 |
$77K |
| 93970 |
|
200 |
186 |
$75K |
| 71250 |
|
240 |
233 |
$75K |
| 92585 |
|
117 |
114 |
$71K |
| 73110 |
|
1,157 |
1,012 |
$70K |
| 76536 |
|
572 |
545 |
$69K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
439 |
369 |
$68K |
| 70496 |
|
132 |
125 |
$66K |
| 70498 |
|
127 |
124 |
$63K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
722 |
707 |
$63K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
681 |
448 |
$62K |
| Z9725 |
|
1,429 |
1,365 |
$61K |
| 84484 |
|
7,139 |
6,172 |
$61K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
927 |
801 |
$55K |
| 0450 |
Emergency room services |
1,372 |
1,251 |
$53K |
| 76801 |
|
353 |
307 |
$51K |
| 92587 |
|
356 |
295 |
$50K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,505 |
5,129 |
$49K |
| 73502 |
|
745 |
704 |
$49K |
| 83690 |
|
8,494 |
7,518 |
$48K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
101 |
96 |
$47K |
| 81001 |
|
8,625 |
7,470 |
$46K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,423 |
2,905 |
$46K |
| 93320 |
|
244 |
230 |
$44K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
532 |
286 |
$42K |
| 92567 |
|
462 |
457 |
$41K |
| 72110 |
|
374 |
364 |
$40K |
| 77049 |
|
56 |
51 |
$39K |
| 73562 |
|
721 |
681 |
$38K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
5,097 |
4,455 |
$37K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,381 |
4,877 |
$35K |
| 73140 |
|
915 |
840 |
$35K |
| 74018 |
|
808 |
750 |
$33K |
| 73080 |
|
496 |
454 |
$32K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,794 |
3,436 |
$31K |
| 96417 |
|
307 |
161 |
$28K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
147 |
143 |
$27K |
| 92550 |
|
525 |
448 |
$25K |
| 90715 |
|
412 |
396 |
$25K |
| 81025 |
|
6,906 |
6,325 |
$24K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,532 |
2,054 |
$24K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,073 |
1,558 |
$22K |
| 73560 |
|
453 |
436 |
$22K |
| 76857 |
|
277 |
252 |
$21K |
| 83605 |
|
2,068 |
1,833 |
$20K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
67 |
64 |
$20K |
| 76870 |
|
139 |
130 |
$18K |
| 80305 |
|
1,477 |
1,395 |
$17K |
| 82947 |
|
3,599 |
2,965 |
$17K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,511 |
2,178 |
$17K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
130 |
101 |
$17K |
| 93017 |
|
92 |
92 |
$16K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
97 |
92 |
$16K |
| 81003 |
|
5,599 |
5,226 |
$16K |
| 83880 |
|
601 |
559 |
$15K |
| 87070 |
|
1,981 |
1,853 |
$15K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
129 |
125 |
$14K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,110 |
1,027 |
$14K |
| 87077 |
|
1,812 |
1,667 |
$13K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,280 |
1,175 |
$13K |
| 72050 |
|
131 |
130 |
$13K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
506 |
448 |
$12K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
504 |
447 |
$12K |
| 87040 |
|
1,054 |
952 |
$12K |
| 92650 |
|
19 |
18 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,543 |
1,450 |
$11K |
| 72040 |
|
203 |
201 |
$11K |
| 83735 |
|
2,112 |
1,819 |
$10K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,060 |
749 |
$10K |
| 73590 |
|
194 |
170 |
$10K |
| 87186 |
|
1,215 |
1,116 |
$10K |
| 85610 |
|
2,888 |
2,613 |
$9K |
| 77080 |
|
122 |
116 |
$9K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,331 |
1,199 |
$8K |
| 85379 |
|
1,112 |
1,054 |
$8K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
55 |
52 |
$8K |
| A4217 |
Sterile water/saline, 500 ml |
655 |
456 |
$8K |
| 92579 |
|
78 |
67 |
$8K |
| 87632 |
|
62 |
53 |
$8K |
| 86901 |
|
3,321 |
2,814 |
$8K |
| J3480 |
Injection, potassium chloride, per 2 meq |
137 |
65 |
$8K |
| 86900 |
|
3,322 |
2,816 |
$8K |
| J7050 |
Infusion, normal saline solution, 250 cc |
4,078 |
2,326 |
$7K |
| J2060 |
Injection, lorazepam, 2 mg |
835 |
705 |
$7K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
755 |
684 |
$7K |
| Z5902 |
|
39 |
39 |
$6K |
| 86850 |
|
2,527 |
2,141 |
$6K |
| 85027 |
|
1,306 |
1,047 |
$6K |
| J1644 |
Injection, heparin sodium, per 1000 units |
276 |
205 |
$6K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
863 |
591 |
$5K |
| 93880 |
|
26 |
26 |
$5K |
| 73100 |
|
109 |
101 |
$5K |
| 82330 |
|
457 |
445 |
$5K |
| 81002 |
|
1,209 |
1,153 |
$5K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
837 |
386 |
$5K |
| Z7610 |
|
458 |
281 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
83 |
70 |
$4K |
| 72170 |
|
75 |
66 |
$4K |
| 92522 |
|
16 |
12 |
$4K |
| 84702 |
|
351 |
292 |
$4K |
| J1453 |
Injection, fosaprepitant, 1 mg |
49 |
25 |
$4K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
15 |
12 |
$4K |
| 86140 |
|
949 |
827 |
$4K |
| 77336 |
|
28 |
12 |
$4K |
| 99199 |
Unlisted special service, procedure or report |
71 |
59 |
$3K |
| 64483 |
|
12 |
12 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
435 |
401 |
$3K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
68 |
25 |
$3K |
| 76882 |
|
120 |
109 |
$3K |
| 12001 |
|
55 |
54 |
$2K |
| 84145 |
|
125 |
110 |
$2K |
| 80051 |
|
409 |
400 |
$2K |
| 82565 |
|
550 |
527 |
$2K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
213 |
187 |
$2K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
59 |
57 |
$2K |
| 84100 |
|
470 |
442 |
$2K |
| 87641 |
|
62 |
56 |
$2K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
163 |
146 |
$1K |
| J1756 |
Injection, iron sucrose, 1 mg |
27 |
12 |
$1K |
| 85730 |
|
330 |
295 |
$1K |
| 72082 |
|
12 |
12 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
34 |
31 |
$1K |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
222 |
193 |
$1K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
163 |
130 |
$1K |
| 84520 |
|
404 |
397 |
$1K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
48 |
44 |
$1K |
| 87510 |
|
62 |
50 |
$926.92 |
| 87480 |
|
62 |
50 |
$926.92 |
| 87660 |
|
62 |
50 |
$926.92 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
969 |
398 |
$926.86 |
| 82962 |
|
264 |
211 |
$860.91 |
| 73070 |
|
16 |
12 |
$839.52 |
| 85014 |
|
332 |
325 |
$803.78 |
| 29125 |
|
47 |
41 |
$797.84 |
| 72070 |
|
12 |
12 |
$785.73 |
| 73090 |
|
14 |
13 |
$723.10 |
| 73565 |
|
14 |
14 |
$682.64 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
80 |
79 |
$643.99 |
| 72020 |
|
14 |
14 |
$639.94 |
| 85652 |
|
308 |
274 |
$614.02 |
| S0028 |
Injection, famotidine, 20 mg |
92 |
67 |
$480.20 |
| 96402 |
|
15 |
12 |
$469.11 |
| 85008 |
|
850 |
745 |
$356.07 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
46 |
38 |
$352.05 |
| 87147 |
|
74 |
69 |
$308.32 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
13 |
13 |
$275.53 |
| 82550 |
|
27 |
24 |
$226.42 |
| 87205 |
|
38 |
38 |
$113.57 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
18 |
16 |
$109.20 |
| 36415 |
Collection of venous blood by venipuncture |
336 |
286 |
$99.97 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
783 |
683 |
$45.63 |
| 85651 |
|
13 |
13 |
$24.70 |
| A6250 |
Skin sealants, protectants, moisturizers, ointments, any type, any size |
782 |
692 |
$24.36 |
| 81005 |
|
17 |
12 |
$22.72 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
78 |
49 |
$21.33 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
101 |
91 |
$14.23 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
72 |
63 |
$3.14 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
13 |
$1.01 |